Biosyent Inc Balance Sheet Statement

RX C$7.65 0.0 0.0%

3:26pm

Balanced, Small Cap, Super Stock

Market Cap £55.3m

Enterprise Value £42.9m

Revenue £12.6m

Quality

Value

Momentum

StockRank™

To unlock Biosyent Inc's balance sheet statement please upgrade your membership.

	2014	2015	2016	2017	2018	2019
Period End:	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31
Period Length:	0	0	0	0	0	0
Currency:	CAD	CAD	CAD	CAD	CAD	CAD

Cash
Short Term Investments
Cash and Short Term Investments
Accounts Receivable - Trade, Net
Total Receivables, Net
Total Inventory
Prepaid Expenses
Other Current Assets, Total
Total Current Assets

Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Property/Plant/Equipment, Total - Net
Intangibles, Net
Note Receivable - Long Term
Other Long Term Assets, Total
Total Assets

Payable/Accrued
Notes Payable/Short Term Debt
Current Port. of LT Debt/Capital Leases
Other Current Liabilities, Total
Total Current Liabilities

Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities

Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Other Equity, Total
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.